SWA
BBIO icon

SOA Wealth Advisors’s BridgeBio Pharma BBIO Stock Holding History

SOA Wealth Advisors’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3K Buy
+98
New +$6.86K ﹤0.01% 655

Other funds holding BBIO

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WMA
Wealth Management Associates Cherry Hill, New Jersey $362M AUM 33.28% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SOA Wealth Advisors's BBIO Position: Q2 2026 in Review

SOA Wealth Advisors opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 98 shares worth $7.3K. The stake represents ﹤0.01% of the portfolio and ranks #655 among its holdings.

54 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • SOA Wealth Advisors held 98 shares of BridgeBio Pharma worth $7.3K as of Q2 2026.
  • BridgeBio Pharma was a new SOA Wealth Advisors position in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #655 holding.
  • 54 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.